Staar Surgical Stock Analysis

STAA Stock  USD 17.72  0.20  1.12%   
STAAR Surgical is undervalued with Real Value of 23.11 and Target Price of 40.98. The main objective of STAAR Surgical stock analysis is to determine its intrinsic value, which is an estimate of what STAAR Surgical is worth, separate from its market price. There are two main types of STAAR Surgical's stock analysis: fundamental analysis and technical analysis.
The STAAR Surgical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and STAAR Surgical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

STAAR Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of STAAR Surgical was at this time reported as 8.06. The company has Price/Earnings (P/E) ratio of 460.83. STAAR Surgical recorded a loss per share of 0.41. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 18th of May 1992. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people. To find out more about STAAR Surgical contact Thomas Frinzi at 626 303 7902 or learn more at https://www.staar.com.

STAAR Surgical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. STAAR Surgical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding STAAR Surgical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
STAAR Surgical generated a negative expected return over the last 90 days
STAAR Surgical has high historical volatility and very poor performance
The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 239.58 M.
STAAR Surgical has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: Staar Surgical Co Shares Down 0 percent on Mar 19

STAAR Surgical Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STAAR Surgical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

STAAR Largest EPS Surprises

Earnings surprises can significantly impact STAAR Surgical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-10-28
2015-09-30-0.04-0.0441-0.004110 
2015-02-25
2014-12-31-0.02-0.03-0.0150 
2013-10-30
2013-09-300.020.01-0.0150 
View All Earnings Estimates

STAAR Surgical Environmental, Social, and Governance (ESG) Scores

STAAR Surgical's ESG score is a quantitative measure that evaluates STAAR Surgical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of STAAR Surgical's operations that may have significant financial implications and affect STAAR Surgical's stock price as well as guide investors towards more socially responsible investments.

STAAR Stock Institutional Investors

Shares
Yunqi Capital Ltd2024-12-31
767.4 K
Millennium Management Llc2024-12-31
759.1 K
Defender Capital, Llc.2024-12-31
701.6 K
Geneva Capital Management2024-12-31
662.8 K
Northern Trust Corp2024-12-31
521.9 K
Palo Alto Investors, Llc2024-12-31
500.8 K
Charles Schwab Investment Management Inc2024-12-31
444.3 K
Bank Of America Corp2024-12-31
439.5 K
Artisan Partners Limited Partnership2024-12-31
439 K
Broadwood Capital Inc2024-12-31
10.8 M
Blackrock Inc2024-12-31
8.2 M
Note, although STAAR Surgical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

STAAR Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 883.91 M.

STAAR Profitablity

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.08 
Return On Capital Employed 0.11  0.12 
Return On Assets 0.08  0.08 
Return On Equity 0.11  0.11 

Management Efficiency

STAAR Surgical has return on total asset (ROA) of (0.0155) % which means that it has lost $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0516) %, meaning that it created substantial loss on money invested by shareholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.12. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 148.7 M, whereas Intangible Assets are forecasted to decline to about 147.9 K.
Last ReportedProjected for Next Year
Book Value Per Share 5.48  5.75 
Tangible Book Value Per Share 5.43  5.71 
Enterprise Value Over EBITDA 112.02  117.62 
Price Book Value Ratio 16.67  26.04 
Enterprise Value Multiple 112.02  117.62 
Price Fair Value 16.67  26.04 
Enterprise Value109.5 M104.1 M
Evaluating the management effectiveness of STAAR Surgical allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The STAAR Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(0.57)
Profit Margin
(0.06)
Beta
0.664
Return On Assets
(0.02)
Return On Equity
(0.05)

Technical Drivers

As of the 22nd of March, STAAR Surgical owns the risk adjusted performance of (0.07), and Standard Deviation of 4.55. In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STAAR Surgical, as well as the relationship between them.

STAAR Surgical Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. STAAR Surgical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for STAAR Surgical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

STAAR Surgical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STAAR Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Broadwood Partners, L.p. 2 days ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Farrell Stephen C few days ago
Disposition of 10000 shares by Farrell Stephen C of STAAR Surgical at 5.54 subject to Rule 16b-3
 
Patrick Williams over a week ago
Disposition of 4061 shares by Patrick Williams of STAAR Surgical subject to Rule 16b-3
 
Butcher Arthur C over a week ago
Acquisition by Butcher Arthur C of 4010 shares of STAAR Surgical at 40.11 subject to Rule 16b-3
 
Farrell Stephen C over two weeks ago
Disposition of 10000 shares by Farrell Stephen C of STAAR Surgical at 8.35 subject to Rule 16b-3
 
Broadwood Partners, L.p. over two weeks ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over two months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Thomas Frinzi over two months ago
Disposition of 10775 shares by Thomas Frinzi of STAAR Surgical at 24.54 subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Patrick Williams over three months ago
Acquisition by Patrick Williams of 24460 shares of STAAR Surgical subject to Rule 16b-3

STAAR Surgical Outstanding Bonds

STAAR Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STAAR Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STAAR bonds can be classified according to their maturity, which is the date when STAAR Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

STAAR Surgical Predictive Daily Indicators

STAAR Surgical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of STAAR Surgical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

STAAR Surgical Corporate Filings

F4
20th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
18th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
14th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
11th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
6th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
3rd of March 2025
Other Reports
ViewVerify
F4
28th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
26th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

STAAR Surgical Forecast Models

STAAR Surgical's time-series forecasting models are one of many STAAR Surgical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STAAR Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About STAAR Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how STAAR Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling STAAR shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as STAAR Surgical. By using and applying STAAR Stock analysis, traders can create a robust methodology for identifying STAAR entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.14  0.14 
Operating Profit Margin 0.14  0.15 
Net Profit Margin 0.12  0.13 
Gross Profit Margin 0.78  0.49 

Current STAAR Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. STAAR analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. STAAR analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
40.98Buy14Odds
STAAR Surgical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most STAAR analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand STAAR stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of STAAR Surgical, talking to its executives and customers, or listening to STAAR conference calls.
STAAR Analyst Advice Details

STAAR Stock Analysis Indicators

STAAR Surgical stock analysis indicators help investors evaluate how STAAR Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading STAAR Surgical shares will generate the highest return on investment. By understating and applying STAAR Surgical stock analysis, traders can identify STAAR Surgical position entry and exit signals to maximize returns.
Begin Period Cash Flow183 M
Common Stock Shares Outstanding49.1 M
Total Stockholder Equity397.3 M
Tax Provision11.2 M
Quarterly Earnings Growth Y O Y1.018
Property Plant And Equipment Net121.8 M
Cash And Short Term Investments230.5 M
Cash144.2 M
Accounts Payable16.7 M
Net Debt-105.4 M
50 Day M A20.1614
Total Current Liabilities70.3 M
Other Operating Expenses326.5 M
Non Current Assets Total141.6 M
Forward Price Earnings625
Non Currrent Assets Other17.2 M
Stock Based Compensation27.2 M

Complementary Tools for STAAR Stock analysis

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets